Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?
Biological medicines contain a biological substance that is produced by or derived from a living organism. The active substances of biologicals are usually larger and more complex than those of chemically derived medicines (non-biological medicine). Biologicals are used for the treatment of chronic...
Gardado en:
| Main Authors: | , , , , |
|---|---|
| Formato: | Revisão |
| Idioma: | inglés |
| Publicado: |
2013
|
| Acceso en liña: | https://doi.org/10.1007/s10198-013-0538-4 https://link.springer.com/content/pdf/10.1007/s10198-013-0538-4.pdf |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|